Arca

Pharma markets this week

Oct 12 to Oct 18, 2026

7 funding rounds, 1 PDUFA date, 13 officer changes.

Funding rounds of $5 million or more, and IPOs 7

Funding rounds

PDUFA dates companies have disclosed 1

PDUFA calendar

Opus Genetics, Inc.

FDA goal date for Phentolamine Ophthalmic Solution 0.75% (sNDA), for presbyopia

2026-10-17 · Disclosed by Opus Genetics, Inc.

Source

Officer and director changes 13

CalciMedica, Inc.

Change in directors or officers

2026-10-16 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Erasca, Inc.

Change in directors or officers

2026-10-16 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Mobia Medical, Inc.

Change in directors or officers

2026-10-16 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Mobia Medical, Inc.

Change in directors or officers

2026-10-16 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

REGENXBIO Inc.

Change in directors or officers

2026-10-16 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

BIOMERICA INC

Change in directors or officers

2026-10-15 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Medline Inc.

Change in directors or officers

2026-10-15 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Longeveron Inc.

Change in directors or officers

2026-10-14 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

LogicMark, Inc.

Change in directors or officers

2026-10-13 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source